CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
Author
A Takla
AR Giuliano
+41Â more
AR Giuliano
AR Giuliano
B Frey Terri
B Serrano
C Burton-Jeangros
CH Mercer
EA Joura
EA Joura
EH Elbasha
EH Elbasha
Federal Office of statistics
Federal Office of Statistics
FOPH
FOPH
FS Mennini
Health Information and Quality Authority
I Baussano
IMS
J Horn
JM Palefsky
Joint Committe on Vaccination and Immunisation
KA Ault
KM French
L Boiron
L Ribassin-Majed
M Jacot-Guillarmod
M Riesen
MN Wymann
N Largeron
National Institute for Cancer EaRN
S Hartwig
S Hartwig
S Hartwig
S Hartwig
SM Garland
SM Garland
SM Matthijsse
Swissmedic
TD Szucs
WHO
YH Choi
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref